LABS vs. IHR, MXF, AGR, PHP, THRL, HWG, MLI, RDI, WHR, and PCTN
Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Target Healthcare REIT (THRL), Harworth Group (HWG), Industrials REIT (MLI), Rdi Reit (RDI), Warehouse REIT (WHR), and Picton Property Income (PCTN). These companies are all part of the "real estate" sector.
Life Science REIT vs. Its Competitors
Life Science REIT (LON:LABS) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.
Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 4.8%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.
67.3% of Life Science REIT shares are owned by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are owned by institutional investors. 7.0% of Life Science REIT shares are owned by company insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.
In the previous week, Life Science REIT's average media sentiment score of 0.00 equaled Impact Healthcare REIT'saverage media sentiment score.
Life Science REIT has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Comparatively, Impact Healthcare REIT has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.
Life Science REIT currently has a consensus price target of GBX 46.50, suggesting a potential upside of 12.05%. Impact Healthcare REIT has a consensus price target of GBX 114, suggesting a potential upside of 0.00%. Given Life Science REIT's higher possible upside, equities analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.
Impact Healthcare REIT received 42 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 77.97% of users gave Impact Healthcare REIT an outperform vote.
Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.
Summary
Impact Healthcare REIT beats Life Science REIT on 11 of the 17 factors compared between the two stocks.
Get Life Science REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Life Science REIT Competitors List
Related Companies and Tools
This page (LON:LABS) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy LABS Stock Free LABS Stock Alerts